{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:15:45Z","timestamp":1774700145427,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Netherlands Organization for Scientific Research","award":["NWA.1162.076"],"award-info":[{"award-number":["NWA.1162.076"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Noonan syndrome spectrum disorders (NSSDs) constitute a group within the Rasopathies, and are one of the largest groups of syndromes with impact on multi-organ involvement known. The extreme variability of the clinical phenotype is, among others, due to the numerous different genes that are involved, and the differences in clinical presentation over the life span. We have studied the needs of patients and their relatives aiming to develop, evaluate and choose focus in research, medical care and policy to better meet their perspectives.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using the participatory and interactive Dialogue method, 80 patients and relatives mentioned 53 different problems or needs (topics) that were categorized into eight themes. These themes and the topics within each theme, were subsequently prioritized by putting them in order of importance methodologically.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The four highest prioritized themes were: (1) Physical problems (non-musculoskeletal related); (2) Social, emotional and behavioral problems; (3) Cognitive functioning and information processing; and (4) Problems related to the musculoskeletal system. Nineteen out of the 53 topics were physical problems. According to the total group of respondents, the top 3 prioritized topics within theme 1 were coagulation problems, heart problems, and feeding problems. Also data stratified by age groups, phenotype (NS and other NSSDs) and gender showed some remarkable results. For instance, feeding problems were prioritized as the most important topic of the highest prioritized theme, according to patients aged 0\u201312 years. Also feeding problems show a significant difference in its prioritization according to female patients (2) compared to male patients (7). On the other hand, heart problems were not mentioned in the top three prioritized topics in the youngest age groups, although heart problems are generally considered most important for patients with NSSD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>With our results we underline the importance of methodologically inventorying the needs of NSSD patients, not only at the group level, but to also focus on specific needs according to e.g. age, phenotype and gender. For instance, it is remarkable that both the current Clinical Guidelines and the Noonan Syndrome diagnostic criteria give little to no attention to feeding problems, though our results indicate that, to the youngest patients, these problems have top priority. A similar situation appears to apply to the clinical management of e.g. coagulation, neuropsychological and musculoskeletal problems (like physiotherapy or occupational therapy) and to a need for (educational) tools to support patients at school or at work. Our study may help to shape targeted (clinical) management, research and policy inside and outside medical (research) institutes and shed light on the complex phenotypes of NSSDs, the families\u2019 and patients\u2019 perspectives on the everyday consequences of the many different problems, as well as their needs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02818-y","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T12:02:01Z","timestamp":1689940921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The most important problems and needs of rasopathy patients with a noonan syndrome spectrum disorder"],"prefix":"10.1186","volume":"18","author":[{"given":"Dagmar K.","family":"Tiemens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte","family":"Kleimeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Wingberm\u00fchle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee L.","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Sibbles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floor S.M.","family":"Oostwegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Vroonland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conny","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanneke","family":"Niessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Sonnega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anniek","family":"Duursma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel A. A. P.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-6173","authenticated-orcid":false,"given":"Jos M. T.","family":"Draaisma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina A.C.M.","family":"Pittens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"2818_CR1","doi-asserted-by":"crossref","unstructured":"Tajan M, Paccoud R, Branka S, Edouard T, Yart A. The RASopathy Family: Consequences of Germline Activation of the RAS\/MAPK Pathway. Endocr Rev. 2018 Oct 1;39(5):676\u2013700.","DOI":"10.1210\/er.2017-00232"},{"issue":"11","key":"2818_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/humu.23624","volume":"39","author":"AR Grant","year":"2018","unstructured":"Grant AR, Cushman BJ, Cave H, Dillon MW, Gelb BD, Gripp KW, et al. Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework. Hum Mutat. 2018;39(11):1485\u201393.","journal-title":"Hum Mutat"},{"key":"2818_CR3","doi-asserted-by":"crossref","unstructured":"Abma TA. Patients as partners in a health research agenda setting: the feasibility of a participatory methodology. Eval Health Prof. 2006 Dec;29(4):424\u201339.","DOI":"10.1177\/0163278706293406"},{"key":"2818_CR4","doi-asserted-by":"crossref","unstructured":"Abma TA, Nierse CJ, Widdershoven GAM. Patients as partners in responsive research: methodological notions of collaborations in mixed research teams. Qual Health Res 2009 Mar:19(3): 401\u201315.","DOI":"10.1177\/1049732309331869"},{"key":"2818_CR5","doi-asserted-by":"crossref","unstructured":"Abma TA, Broerse JEW. Patient participation as dialogue: setting research agendas. Health Expect 2010 Jun: 13(2): 160\u201373.","DOI":"10.1111\/j.1369-7625.2009.00549.x"},{"issue":"11","key":"2818_CR6","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.socscimed.2004.11.023","volume":"60","author":"JF Caron-Flinterman","year":"2005","unstructured":"Caron-Flinterman JF, Broerse JE, Bunders JF. The experiential knowledge of patients: a new resource for biomedical research? Soc Sci Med. 2005;60(11):2575\u201384.","journal-title":"Soc Sci Med"},{"issue":"6990","key":"2818_CR7","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1136\/bmj.310.6990.1277","volume":"310","author":"H Goodare","year":"1995","unstructured":"Goodare H, Smith R. The rights of patients in research. BMJ. 1995;310(6990):1277\u20138.","journal-title":"BMJ"},{"issue":"4","key":"2818_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1369-7625.2010.00652.x","volume":"14","author":"V Edwards","year":"2011","unstructured":"Edwards V, Wyatt K, Logan S, Britten N. Consulting parents about the design of a randomized controlled trial of osteopathy for children with cerebral palsy. Health Expect. 2011;14(4):429\u201338.","journal-title":"Health Expect"},{"issue":"7129","key":"2818_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/bmj.316.7129.463","volume":"316","author":"VA Entwistle","year":"1998","unstructured":"Entwistle VA, Renfrew MJ, Yearly S, Forrester J, Lamont T. BMJ. 1998;316(7129):463\u20136.","journal-title":"BMJ"},{"issue":"6","key":"2818_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/scipol\/scu010","volume":"41","author":"CACM Pittens","year":"2014","unstructured":"Pittens CACM, Elberse JE, Visse M, Abma TA, Broerse JEW. Research agenda\u2019s involving patients: factors that facilitate or impede translation of patients perspectives in programming and implementation. Sci Public Policy. 2014;41(6):809\u201320. (Mar);.","journal-title":"Sci Public Policy"},{"issue":"1","key":"2818_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13023-021-02083-x","volume":"16","author":"DK Tiemens","year":"2021","unstructured":"Tiemens DK, Nugteren J, Leenders E, Wingberm\u00fchle E, Pittens CACM, Draaisma JMT. Patient engagement in the design of clinical research in Noonan syndrome spectrum disorders: a scoping review. Orphanet J Rare Dis. 2021;16(1):449. https:\/\/doi.org\/10.1186\/s13023-021-02083-x.","journal-title":"Orphanet J Rare Dis"},{"key":"2818_CR12","doi-asserted-by":"crossref","unstructured":"Elberse JE, Caron-Flinterman JF, Broerse JE. Patient-expert partnerships in research: how to stimulate inclusion of patient perspectives. Health Expect. 2011 Sep;14(3):225\u201339.","DOI":"10.1111\/j.1369-7625.2010.00647.x"},{"key":"2818_CR13","unstructured":"Zorgstandaard Noonan Syndroom (in Dutch). https:\/\/noonansyndroom.nl\/de-juiste-zorg-voor-noonan-syndroom-zorgstandaard. Accessed Oct 2019 and 6 Nov 2022."},{"key":"2818_CR14","doi-asserted-by":"crossref","unstructured":"Gripp KW, Schill L, Schoyer L, Stronach B, Bennett AM, Blaser S et al. The sixth international RASopathies symposium: Precision medicine-From promise to practice. Am J Med Genet A. 2020;182(3):597\u2013606.","DOI":"10.1002\/ajmg.a.61434"},{"key":"2818_CR15","doi-asserted-by":"crossref","unstructured":"Kontaridis MI, Roberts AE, Schill L, Schoyer L, Stronach B, Andelfinger G et al. The seventh international RASopathies symposium: Pathways to cure-expanding knowledge, enhancing research and therapeutic discovery. Am J Med Genet A. 2022 Jun;188(6):1915\u20131927.","DOI":"10.1002\/ajmg.a.62716"},{"key":"2818_CR16","doi-asserted-by":"publisher","unstructured":"Garcia-Minaur S, Burkitt-Wright E, Verloes A, Shaikd G, Lebl J, Ostman-Smith I, et al. European medical education initiative on Noonan syndrome: a clinical practice survey assessing the diagnosis and clinical management of individuals with Noonan syndrome across Europe. Eur J Med Genet. 2022 Jan;65(1):104371. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104371.","DOI":"10.1016\/j.ejmg.2021.104371"},{"key":"2818_CR17","doi-asserted-by":"crossref","unstructured":"Nugent DJ, Romano AA, Sabharwal S, Cooper DL. Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review. J Blood Med. 2018 Oct;23:9:185\u201392.","DOI":"10.2147\/JBM.S164474"},{"key":"2818_CR18","doi-asserted-by":"crossref","unstructured":"Andelfinger G, Marquis C, Raboisson MJ, Th\u00e9oret Y, Waldm\u00fcller S, Wiegand G, et al. Hypertrophic cardiomyopathy in Noonan Syndrome treated by MEK-Inhibition. J Am Coll Cardiol. 2019 May;7(17):2237\u20139.","DOI":"10.1016\/j.jacc.2019.01.066"},{"key":"2818_CR19","doi-asserted-by":"crossref","unstructured":"Nakano TA, Rankin AW, Annam A, Kulungowski AM, McCallen LM, Hill LR, et al. Trametinib for refractory chylous effusions and systemic complications in children with Noonan syndrome. J pediatr. 2022 Sep;248:82\u201388e1.","DOI":"10.1016\/j.jpeds.2022.05.030"},{"issue":"4","key":"2818_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/ajmg.a.61485","volume":"182","author":"AM Gross","year":"2020","unstructured":"Gross AM, Frone M, Gripp KW, Gelb BD, Schoyer L, Schill L, et al. Advancing RAS\/RASopathy therapies: an NCI-sponsored intramural and extramural collaboration for the study of RASopathies. Am J Med Genet A. 2020;182(4):866\u201376.","journal-title":"Am J Med Genet A"},{"key":"2818_CR21","doi-asserted-by":"publisher","unstructured":"van der Burgt. Noonan syndrome. Orphanet J Rare Dis. 2007 Jan;14:2:4. https:\/\/doi.org\/10.1186\/1750-1172-2-4.","DOI":"10.1186\/1750-1172-2-4"},{"key":"2818_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuropharm.2015.11.023","volume":"103","author":"W Zhong","year":"2016","unstructured":"Zhong W, Chebolu S, Darmani NA. Thapsigargin-Induced activation of Ca2+-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew. Neuropharmacology. 2016;103:195\u2013210.","journal-title":"Neuropharmacology"},{"issue":"3","key":"2818_CR23","doi-asserted-by":"publisher","first-page":"e247513","DOI":"10.1136\/bcr-2021-247513","volume":"15","author":"D Tiemens","year":"2022","unstructured":"Tiemens D, van Wegberg A, van Druten D, Draaisma J. High energy expenditure in a patient with feeding problems and Noonan syndrome spectrum disorder. BMJ Case Rep. 2022;15(3):e247513. https:\/\/doi.org\/10.1136\/bcr-2021-247513.","journal-title":"BMJ Case Rep"},{"key":"2818_CR24","doi-asserted-by":"crossref","unstructured":"Bryant-Waugh R. Avoidant\/Restrictive food intake disorder. Child Adolesc Psychiatr Clin N am. 2019 Oct;28(4):557\u201365.","DOI":"10.1016\/j.chc.2019.05.004"},{"key":"2818_CR25","doi-asserted-by":"crossref","unstructured":"Croonen EA, Harmsen M, Van der Burgt I, Draaisma JM, Noordam K, Essink M, et al. Perceived motor problems in daily life: Focus group interviews with people with Noonan syndrome and their relatives. Am J Med Genet A. 2016 Sep;170(9):2349\u201356.","DOI":"10.1002\/ajmg.a.37814"},{"key":"2818_CR26","doi-asserted-by":"crossref","unstructured":"Croonen EA, Essink M, van der Burgt I, Draaisma JM, Noordam C, Nijhuis-van der Sanden MWG. Motor performance in children with Noonan syndrome. Am J Med Genet A. 2017 Sep;173(9):2335\u201345.","DOI":"10.1002\/ajmg.a.38322"},{"key":"2818_CR27","doi-asserted-by":"crossref","unstructured":"de Ridder W, van Engelen B, van Alfen N. Neurological features of Noonan syndrome and related RASopathies: pain and nerve enlargement characterized by nerve ultrasound. Am J Med Genet A. 2022 Jun;188(6):1801\u20137.","DOI":"10.1002\/ajmg.a.62714"},{"key":"2818_CR28","doi-asserted-by":"crossref","unstructured":"Roelofs RL, Wingberm\u00fchle E, van der Heijden PT, Jonkers R, de Haan M, Kessels RPC, Egger JIM. Personality and psychopathology in adults with Noonan Syndrome. J Clin Psychol Med Settings. 2020 Jun;27(2):256\u201367.","DOI":"10.1007\/s10880-019-09659-7"},{"key":"2818_CR29","doi-asserted-by":"publisher","unstructured":"Wingberm\u00fchle E, Roelofs RL, Oomens W, Kramer J, Draaisma JMT, Leenders E et al. Cognitive phenotype and psychopathology in Noonan syndrome spectrum disorders through various Ras\/MAPK pathway associated gene variants. J Clin Me 2022 Aug 13;11(16);4735. Doi: https:\/\/doi.org\/10.3390\/jcm11164735.","DOI":"10.3390\/jcm11164735"},{"key":"2818_CR30","doi-asserted-by":"crossref","unstructured":"Pierpont EI, Wolford M. Behavioral functioning in cardiofaciocutaneous syndrome: risk factors and impact on parenting experience. Am J Med Genet A. 2016 Aug;170(8):1974\u201388.","DOI":"10.1002\/ajmg.a.37725"},{"key":"2818_CR31","doi-asserted-by":"crossref","unstructured":"Roelofs RL, Wingberm\u00fchle E, Kessels RPC, Egger JIM. Social cognitive training for adults with Noonan syndrome: a feasibility study. Neuropsychiatr Dis Treat 2019 Feb 26;15:611\u201326.","DOI":"10.2147\/NDT.S179527"},{"issue":"9","key":"2818_CR32","first-page":"1725","volume":"179","author":"KW Gripp","year":"2019","unstructured":"Gripp KW, Morse LA, Axelrad M, Chatfield KC, Chidekel A, Dobyns D, et al. Costello syndrome: clinical phenotype, genotype, and management guidelines. AJMG. 2019;179(9):1725\u201344.","journal-title":"AJMG"},{"key":"2818_CR33","doi-asserted-by":"publisher","first-page":"104372","DOI":"10.1016\/j.ejmg.2021.104372","volume":"65","author":"CM Wolf","year":"2022","unstructured":"Wolf CM, Zenker M, Burkitt-Wright E, Edouard T, Garcia-Minaur S, Lebl J, et al. Management of cardiac aspects in children with Noonan syndrome-results from a european clinical practice survey among paediatric cardiologists. Eur J Med Genet. 2022;65:104372. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104372.","journal-title":"Eur J Med Genet"},{"key":"2818_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/adc.67.2.178","volume":"67","author":"M Sharland","year":"1992","unstructured":"Sharland M, Burch M, McKenna WM. Patton M.A. A clinical study of Noonan syndrome. Arch Dis Child. 1992;67:178\u201383.","journal-title":"Arch Dis Child"},{"key":"2818_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/adc.2006.104547","volume":"92","author":"AC Shaw","year":"2007","unstructured":"Shaw AC, Kalidas K, Crosby AH, Jeffery S, Patton MA. The natural history of Noonan syndrome: a long term study. Arch Dis Child. 2007;92:128\u201332.","journal-title":"Arch Dis Child"},{"key":"2818_CR36","doi-asserted-by":"publisher","unstructured":"Tiemens DK, van Haaften L, Leenders E, van Wegberg AMJ, Gunther Moor B, Geelen J et al. Feeding problems in patients with Noonan syndrome: a narrative review. J Clin Med 2022 Jan 30;11(3):754. Doi: https:\/\/doi.org\/10.3390\/jcm11030754.","DOI":"10.3390\/jcm11030754"},{"issue":"10","key":"2818_CR37","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1128\/MCB.06712-11","volume":"32","author":"Z He","year":"2012","unstructured":"He Z, Zhang SS, Meng Q, Li S, Zhu HH, Raquil MA, Alder son N, Zhang H, Wu J, Rui L, Cai D, Feng GS. Shp2 controls female body weight and energybalance by integrating leptin and estrogen signals. Mol Cell Biol. 2012;32(10):1867\u201378.","journal-title":"Mol Cell Biol"},{"key":"2818_CR38","doi-asserted-by":"publisher","unstructured":"da Silva FM, Jorge AA, Malaquias A, et al. Nutritional aspects of Noonan syndrome and Noonan-related disorders. Am J Med Genet A. 2016 June;70(6):1525\u201331. https:\/\/doi.org\/10.1002\/ajmg.a.37639.","DOI":"10.1002\/ajmg.a.37639"},{"key":"2818_CR39","doi-asserted-by":"publisher","unstructured":"Malaquias AC, Brasil AS, Pereira AC, et al. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS\/MAPK pathway. Am J Med Genet A. 2012 Nov;158A(11):2700\u20136. https:\/\/doi.org\/10.1002\/ajmg.a.35519.","DOI":"10.1002\/ajmg.a.35519"},{"key":"2818_CR40","doi-asserted-by":"crossref","unstructured":"Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, Roberts AE, Robinson W, Takemoto CM, Noonan JA. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010 Oct;126(4):746\u201359.","DOI":"10.1542\/peds.2009-3207"},{"key":"2818_CR41","unstructured":"Noonan Syndrome Awareness Association. Teaching strategies for Noonan Syndrome. https:\/\/noonansyndrome.com.au\/wp-content\/uploads\/2016\/10\/NSAA-Teaching-Strategies-for-NS.pdf. Assessed 6 Nov 2022."},{"key":"2818_CR42","unstructured":"Clifford M, Pierpont R. Attention and executive function concerns in children with Noonan Syndrome: a guide for teachers. https:\/\/wessland.com\/Attention_and_Executive_Function_Concerns_in_Children_with_Noonan_Syndrome.pdf. Assessed 6 Nov 2022."},{"issue":"2","key":"2818_CR43","first-page":"53","volume":"33","author":"NL Mudrick","year":"2014","unstructured":"Mudrick NL, Gartin BC. Educational implications of Costello syndrome: the team approach. Phys Disabilities: Educ Relat Serv. 2014;33(2):53\u201370.","journal-title":"Phys Disabilities: Educ Relat Serv"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02818-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02818-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02818-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:02:16Z","timestamp":1689984136000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02818-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2818"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02818-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"29 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}